Literature DB >> 8064682

Effect of tumour necrosis factor alpha on rat blastocyst growth and glucose metabolism.

S Pampfer1, B Moulaert, I Vanderheyden, Y D Wuu, R De Hertogh.   

Abstract

Tumour necrosis factor alpha (TNF-alpha) synthesis has recently been described in the uterus during the preimplantation phase of pregnancy. The present study was undertaken to determine whether preimplantation embryos are a potential target for TNF-alpha in rats. First, the expression of TNF-alpha receptors by blastocysts was demonstrated by ligand binding assay with human 125I-labelled TNF-alpha and reverse transcription-amplification for the p60 receptor form. The functionality of these receptors was then assessed by incubating blastocysts with 3 nmol mouse TNF-alpha l-1 in vitro and determining their morphology and the number of cells after 24 h. At that concentration, cell proliferation in blastocysts was inhibited by TNF-alpha but this was not accompanied by any change in the morphology of the embryos. Similar results were obtained when lower doses of TNF-alpha (30 and 300 pmol l-1) were tested. The rate of glucose consumption of rat blastocysts exposed to 3 nmol TNF-alpha l-1 was not altered when they were incubated with the cytokine for 4 h, but the rate of glucose incorporation decreased over the same period. Our data indicate that rat blastocysts are responsive to physiological concentration of TNF-alpha and that this cytokine has the potential to influence the preimplantation development of rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064682     DOI: 10.1530/jrf.0.1010199

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  2 in total

Review 1.  Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium.

Authors:  S Haider; M Knöfler
Journal:  Placenta       Date:  2008-11-22       Impact factor: 3.481

2.  Melatonin improves development of early mouse embryos impaired by actinomycin-D and TNF-α.

Authors:  Behrooz Niknafs; Ahmad Mehdipour; Amaneh Mohammadi Roushandeh
Journal:  Iran J Reprod Med       Date:  2014-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.